Spotlight Therapeutics
ID: 6552798Spotlight Therapeutics is an in vivo Gene Editing founded in 2017 by Patrick Hsu, Alexander Marson and Jacob Corn.
3
Funding Rounds
$117.5m
Money raised
Recent Funding Rounds
Overview
Spotlight Therapeutics is an in vivo Gene Editing founded in 2017 by Patrick Hsu, Alexander Marson and Jacob Corn.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa***** Hs* | - | - | - |
| Al******* Ma**** | - | - | - |
| Ja*** Co** | - | - | - |
Funding series
Funding Series Analysis
The company Spotlight Therapeutics has raised a total of $101.5m in funding over 3 rounds.
Key Insights:
- Spotlight Therapeutics Series B round, March 2022: $36.5m
- Spotlight Therapeutics Funding Round, January 2022: $65m
- Spotlight Therapeutics, Inc. funding round, October 2020: $16m
Industries
Spotlight Therapeutics is active in the following industries: